Back to top
more

QuidelOrtho (QDEL)

(Real Time Quote from BATS)

$42.68 USD

42.68
722,424

+3.00 (7.56%)

Updated May 2, 2024 12:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.20%
2Buy18.04%
3Hold9.52%
4Sell5.20%
5Strong Sell2.60%
S&P50011.13%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

5-Strong Sell of 5         5

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value D Growth F Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 40% (151 out of 251)

Industry: Medical - Products

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

Can Quidel (QDEL) Run Higher on Strong Earnings Estimate Revisions?

by Zacks Equity Research

Quidel (QDEL) is seeing positive earnings estimate revisions, suggesting that it could be a solid choice for investors.

    Nalak Das headshot

    Major Indexes Defying "Sell in May" Adage: 5 Growth Picks

    by Nalak Das

    Half of this month is already over, yet Wall Street is in green defying the well-known financial-world adage "Sell in May and go away."

    Quidel (QDEL) in Focus: Stock Moves 6.2% Higher

    by Zacks Equity Research

    Quidel (QDEL) saw a big move last session, as its shares jumped more than 6% on the day, amid huge volumes.

    Top Ranked Momentum Stocks to Buy for May 18th

    by Zacks Equity Research

    Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, May 18th

    Neena Mishra headshot

    Healthcare Tech & Robotics ETFs in Focus amid COVID-19 Crisis

    by Neena Mishra

    The pandemic will forever transform our lives; here are some areas that may benefit.

    Looking for a Growth Stock? 3 Reasons Why Quidel (QDEL) is a Solid Choice

    by Zacks Equity Research

    Quidel (QDEL) is well positioned to outperform the market, as it exhibits above-average growth in financials.

    Is Quidel (QDEL) Outperforming Other Medical Stocks This Year?

    by Zacks Equity Research

    Is (QDEL) Outperforming Other Medical Stocks This Year?

    The Zacks Analyst Blog Highlights: Pluralsight, Quidel, Vista Outdoor, SunOpta and Nautilus

    by Zacks Equity Research

    The Zacks Analyst Blog Highlights: Pluralsight, Quidel, Vista Outdoor, SunOpta and Nautilus

    The Zacks Analyst Blog Highlights: Wayfair, Chegg, Moderna, Quidel and Clorox

    by Zacks Equity Research

    The Zacks Analyst Blog Highlights: Wayfair, Chegg, Moderna, Quidel and Clorox

    5 Stocks to Buy as America Prepares to Reopen Economy

    by Zacks Equity Research

    As the U.S. economy prepares to reopen, here are five growth stocks to invest in to earn significantly higher returns.

    Nalak Das headshot

    An Outstanding Week for Market Amid Record Job Losses: 5 Picks

    by Nalak Das

    Market's worst is behind us as negative estimates are already factored in valuations.

    Quidel (QDEL) Beats Q1 Earnings and Revenue Estimates

    by Zacks Equity Research

    Quidel (QDEL) delivered earnings and revenue surprises of 22.00% and 11.16%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?

    What's in the Cards for Quidel (QDEL) This Earnings Season?

    by Zacks Equity Research

    Quidel (QDEL) is expected to have gained from its Molecular Diagnostic Solutions business in Q1.

    Ritujay Ghosh headshot

    Trump Pushes for US-Made Medical Products: 4 Winners

    by Ritujay Ghosh

    An executive order to address the lack of medical product manufacturing in the United States could in a way boost manufacturing and sales of home-grown goods.

    Quidel (QDEL) Earnings Expected to Grow: Should You Buy?

    by Zacks Equity Research

    Quidel (QDEL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

    Quidel (QDEL) is an Incredible Growth Stock: 3 Reasons Why

    by Zacks Equity Research

    Quidel (QDEL) is well positioned to outperform the market, as it exhibits above-average growth in financials.

    Should You Invest in the SPDR S&P Health Care Equipment ETF (XHE)?

    by Zacks Equity Research

    Sector ETF report for XHE

    The Zacks Analyst Blog Highlights: Danaher, Quidel, Aytu BioScience, QIAGEN and Co-Diagnostics

    by Zacks Equity Research

    The Zacks Analyst Blog Highlights: Danaher, Quidel, Aytu BioScience, QIAGEN and Co-Diagnostics

    Coronavirus Test Kit Demand to Drive These 3 Stocks

    by Zacks Equity Research

    Point-of-care testing enables better patient triage, bed management, and patient care decisions. Here are three stocks to benefit as demand rises.

    Quidel (QDEL) Looks Good: Stock Adds 10.8% in Session

    by Zacks Equity Research

    Quidel (QDEL) saw a big move last session, as its shares jumped nearly 11% on the day, amid huge volumes.

    Earnings Preview: Quidel (QDEL) Q4 Earnings Expected to Decline

    by Zacks Equity Research

    Quidel (QDEL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

    Quidel (QDEL) Surpasses Q3 Earnings and Revenue Estimates

    by Zacks Equity Research

    Quidel (QDEL) delivered earnings and revenue surprises of 7.69% and 0.69%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?

    Quidel (QDEL) Reports Next Week: Wall Street Expects Earnings Growth

    by Zacks Equity Research

    Quidel (QDEL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

    Quidel (QDEL) Q2 Earnings Meet Estimates

    by Zacks Equity Research

    Quidel (QDEL) delivered earnings and revenue surprises of 0.00% and 0.26%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?

    Quidel (QDEL) Reports Next Week: Wall Street Expects Earnings Growth

    by Zacks Equity Research

    Quidel (QDEL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.